Yusuke Takeda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yusuke Takeda has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Masayuki Takamura
Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
6 shared publications - Shinichiro Takashima
Kanazawa University
6 shared publications - Soichiro Usui
Kanazawa University
6 shared publications - Oto Inoue
Division of Molecular Cardiovascular Biology, The Heart Institute, Cincinnati Children’s Hospital Medical Center Cincinnati
5 shared publications Ayano Nomura
4 shared publicationsDaiki Hashimuko
4 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 48
Hepatocyte-derived selenoprotein P contributes to pressure overload–induced cardiac remodeling
- 26 October 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 48
Open AccessHepatocyte-derived selenoprotein P contributes to pressure overload–induced cardiac remodeling
- Open Access
- 8 May 2026
- Published by Elsevier in Regenerative Therapy
- Vol. 32, 101125
Transient epigenetic changes promote cardiomyocyte differentiation of the subcutaneous adipose stromal vascular fraction
- 8 May 2026
- Published by Elsevier in Regenerative Therapy
- Vol. 32, 101125
Open AccessTransient epigenetic changes promote cardiomyocyte differentiation of the subcutaneous adipose stromal vascular fraction
- 1 August 2025
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 329 (2) , R287-R296
Heart failure decreases adipocyte progenitors with impaired differentiation capacity toward mature adipocytes
Our work elucidated the negative feedback between heart failure (HF) and the number and function of adipocyte progenitor cells (APCs). HF drastically decreases CD24+ APC number and proliferative capacity. Furthermore, we discovered that HF impaired the capacity of APCs to differentiate into mature adipocytes. In conclusion, impaired APC function in HF would be a new research target to ameliorate severe HF outcomes in patients with cachexia.
- 1 August 2025
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 329 (2) , R287-R296
Heart failure decreases adipocyte progenitors with impaired differentiation capacity toward mature adipocytes
Our work elucidated the negative feedback between heart failure (HF) and the number and function of adipocyte progenitor cells (APCs). HF drastically decreases CD24+ APC number and proliferative capacity. Furthermore, we discovered that HF impaired the capacity of APCs to differentiate into mature adipocytes. In conclusion, impaired APC function in HF would be a new research target to ameliorate severe HF outcomes in patients with cachexia.
- Open Access
- 1 February 2025
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 328 (2) , C414-C428
Bone marrow-derived NGFR-positive dendritic cells regulate arterial remodeling
We propose a new concept of arterial remodeling after injury in which bone marrow-derived NGFR+ dendritic cells inhibit neointimal progression mediated by apoptosis. NGFR+ dendritic cells promote anti-inflammatory MRC1+ M2 macrophage accumulation and production of interleukin-10, inhibiting smooth muscle cell proliferation within the neointima. In a clinical study, insufficient mobilization of NGFR+ peripheral mononuclear cells in acute coronary syndrome was an independent risk factor for 9-mo nontargeted coronary intimal progression.
- 1 February 2025
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 328 (2) , C414-C428
Open AccessBone marrow-derived NGFR-positive dendritic cells regulate arterial remodeling
We propose a new concept of arterial remodeling after injury in which bone marrow-derived NGFR+ dendritic cells inhibit neointimal progression mediated by apoptosis. NGFR+ dendritic cells promote anti-inflammatory MRC1+ M2 macrophage accumulation and production of interleukin-10, inhibiting smooth muscle cell proliferation within the neointima. In a clinical study, insufficient mobilization of NGFR+ peripheral mononuclear cells in acute coronary syndrome was an independent risk factor for 9-mo nontargeted coronary intimal progression.
- Open Access
Single cell transcriptomics identifies adipose tissue CD271+ progenitors for enhanced angiogenesis in limb ischemia
SUMMARY: Therapeutic angiogenesis using mesenchymal stem/stromal cell grafts have shown modest and controversial effects in preventing amputation for patients with critical limb ischemia. Through single-cell transcriptomic analysis of human tissues, we identified CD271 + progenitors specifically from subcutaneous adipose tissue (AT) as having the most prominent pro-angiogenic gene profile distinct from other stem cell populations. AT-CD271 + progenitors demonstrated robust in vivo angiogenic capacity, over conventional adipose stromal cell grafts, characterized by long-term engraftment, augmented tissue regeneration, and significant recovery of blood flow in a xenograft model of limb ischemia. Mechanistically, the angiogenic capacity of CD271 + progenitors is dependent on functional CD271 and mTOR signaling. Notably, the number and angiogenic capacity of CD271 + progenitors was strikingly reduced in insulin resistant donors. Our study highlights the identification of AT-CD271 + progenitors with in vivo superior efficacy for limb ischemia. Furthermore, we showcase comprehensive single-cell transcriptomics strategies for identification of suitable grafts for cell therapy. HIGHLIGHTS: Adipose tissue stromal cells have a distinct angiogenic gene profile among human cell sources. CD271 + progenitors in adipose tissue have a prominent angiogenic gene profile. CD271 + progenitors show superior therapeutic capacities for limb ischemia. CD271 + progenitors are reduced and functionally impaired in insulin resistant donors. GRAPHICAL
Open AccessSingle cell transcriptomics identifies adipose tissue CD271+ progenitors for enhanced angiogenesis in limb ischemia
SUMMARY: Therapeutic angiogenesis using mesenchymal stem/stromal cell grafts have shown modest and controversial effects in preventing amputation for patients with critical limb ischemia. Through single-cell transcriptomic analysis of human tissues, we identified CD271 + progenitors specifically from subcutaneous adipose tissue (AT) as having the most prominent pro-angiogenic gene profile distinct from other stem cell populations. AT-CD271 + progenitors demonstrated robust in vivo angiogenic capacity, over conventional adipose stromal cell grafts, characterized by long-term engraftment, augmented tissue regeneration, and significant recovery of blood flow in a xenograft model of limb ischemia. Mechanistically, the angiogenic capacity of CD271 + progenitors is dependent on functional CD271 and mTOR signaling. Notably, the number and angiogenic capacity of CD271 + progenitors was strikingly reduced in insulin resistant donors. Our study highlights the identification of AT-CD271 + progenitors with in vivo superior efficacy for limb ischemia. Furthermore, we showcase comprehensive single-cell transcriptomics strategies for identification of suitable grafts for cell therapy. HIGHLIGHTS: Adipose tissue stromal cells have a distinct angiogenic gene profile among human cell sources. CD271 + progenitors in adipose tissue have a prominent angiogenic gene profile. CD271 + progenitors show superior therapeutic capacities for limb ischemia. CD271 + progenitors are reduced and functionally impaired in insulin resistant donors. GRAPHICAL
- 1 September 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 517 (2) , 369-375
Diabetes impairs the angiogenic capacity of human adipose-derived stem cells by reducing the CD271+ subpopulation in adipose tissue
- 1 September 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 517 (2) , 369-375
Diabetes impairs the angiogenic capacity of human adipose-derived stem cells by reducing the CD271+ subpopulation in adipose tissue